Abiopharma

New Form 8-K - Cingulate Inc. Filed: 2025-05-13 AccNo: 0001641172-25-009989 Size: 246 KB Item 1.02: Termination of a Material Definitive Agreement

Novanta - Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025

New Form 4 - PROCEPT BioRobotics Corp Filed: 2025-05-13 AccNo: 0001628280-25-025179 Size: 6 KB

Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025

New Form 10-Q - Lucid Diagnostics Inc. Filed: 2025-05-13 AccNo: 0001641172-25-009986 Size: 5 MB

New Form 10-Q - Flora Growth Corp. Filed: 2025-05-13 AccNo: 0001062993-25-009247 Size: 9 MB

New Form 8-K - PMGC Holdings Inc. Filed: 2025-05-13 AccNo: 0001213900-25-042717 Size: 288 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Tenon Medical, Inc. Filed: 2025-05-13 AccNo: 0001213900-25-042714 Size: 4 MB

New Form 10-Q - ELUTIA INC. Filed: 2025-05-13 AccNo: 0001558370-25-007586 Size: 8 MB

New Form S-3 - Verastem, Inc. Filed: 2025-05-13 AccNo: 0001104659-25-047877 Size: 325 KB

New Form S-8 - Verrica Pharmaceuticals Inc. Filed: 2025-05-13 AccNo: 0001193125-25-118881 Size: 70 KB

New Form 8-K - Spero Therapeutics, Inc. Filed: 2025-05-13 AccNo: 0001193125-25-118882 Size: 197 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G/A - LENSAR, Inc. Filed: 2025-05-13 AccNo: 0000950170-25-070486 Size: 6 KB

New Form 4 - Zai Lab Ltd Filed: 2025-05-13 AccNo: 0000905148-25-001598 Size: 4 KB